$43.36
1.162.75%
In chiusura: Nov 26, 4:00 PM EST
$43.60
0.240.55%
After hour: Nov 26, 4:43 PM EST
Mineralys Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Mineralys Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
MLYS | Mineralys Therapeutics | -$0.98 | -$0.54 | — | — | $0.00 | — | — | — | 02/11/2026 | |
MLYS | Mineralys Therapeutics | -$1.13 | -$0.63 | -$0.52 | 17.46% | $0.00 | — | $0.00 | — | 11/10/2025 | |
MLYS | Mineralys Therapeutics | -$0.83 | -$0.76 | -$0.66 | 13.16% | $0.00 | — | $0.00 | — | 08/12/2025 | |
MLYS | Mineralys Therapeutics | -$0.70 | -$0.98 | -$0.79 | 19.39% | $0.00 | — | $0.00 | — | 05/12/2025 | |
MLYS | Mineralys Therapeutics | -$0.61 | -$1.08 | -$0.98 | 9.26% | $0.00 | — | $0.00 | — | 02/12/2025 | |
MLYS | Mineralys Therapeutics | -$0.57 | -$0.83 | -$1.13 | -36.14% | $0.00 | — | $0.00 | — | 11/11/2024 | |
MLYS | Mineralys Therapeutics | -$0.31 | -$0.70 | -$0.83 | -18.57% | $0.00 | — | $0.00 | — | 08/13/2024 | |
MLYS | Mineralys Therapeutics | -$0.51 | -$0.67 | -$0.70 | -4.48% | $0.00 | — | $0.00 | — | 05/09/2024 | |
MLYS | Mineralys Therapeutics | -$1.74 | -$0.82 | -$0.61 | 25.61% | $0.00 | — | $0.00 | — | 03/21/2024 | |
MLYS | Mineralys Therapeutics | -$1.29 | -$0.76 | -$0.57 | 25.00% | — | — | $0.00 | — | 11/07/2023 | |
MLYS | Mineralys Therapeutics | -$1.26 | -$0.83 | -$0.31 | 62.65% | $0.00 | — | $0.00 | — | 08/07/2023 | |
MLYS | Mineralys Therapeutics | -$1.48 | -$0.89 | -$0.51 | 42.70% | $0.00 | — | $0.00 | — | 05/15/2023 | |
MLYS | Mineralys Therapeutics | — | -$1.72 | -$1.74 | -1.16% | — | — | $0.00 | — | 03/15/2023 |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-10 | $-0.52 | $-0.63 | 17.5 % |
| Q2 | 2025-08-12 | $-0.66 | $-0.76 | 13.2 % |
| Q1 | 2025-05-12 | $-0.79 | $-0.98 | 19.4 % |
| Q4 | 2025-02-12 | $-0.98 | $-1.08 | 9.26 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
Si prevede che Mineralys Therapeutics (MLYS) fornisca risultati il febbraio 11, 2026. Gli ultimi risultati sono stati pubblicati il novembre 10, 2025 per il Q3.
L'EPS effettivo era $-0.52, che superato la stima di $-0.63.
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.